Average Co-Inventor Count = 9.18
ph-index = 3
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Janssen Pharmaceutica Nv (7 from 2,079 patents)
2. Novartis Ag (4 from 3,924 patents)
3. Janssen Sciences Ireland Unlimited Company (2 from 61 patents)
4. Janssen Biotech, Inc. (411 patents)
13 patents:
1. 11491148 - Amide derivatives useful in the treatment of HBV infection or HBV-induced diseases
2. 11236084 - Substituted azaindoline derivatives as NIK inhibitors
3. 11186589 - Cyanoindoline derivatives as NIK inhibitors
4. 11180487 - Substituted cyanoindoline derivatives as NIK inhibitors
5. 11136311 - Heteroaromatic derivatives as NIK inhibitors
6. 11096931 - Amide derivatives useful in the treatment of HBV infection or HBV-induced diseases
7. 11053248 - [1,2,4]triazolo[1,5-a]pyrimidine compounds as PDE2 inhibitors
8. 11001569 - 6-membered heteroaromatic substituted cyanoindoline derivatives as NIK inhibitors
9. 10947242 - [1,2,4]triazolo[1,5and#8208;A]pyrimidine compounds as PDE2 inhibitors
10. 9649314 - Pyrimido[4,5-b]quinoline-4,5(3H,10H)-diones
11. 9051279 - Substituted isoquinolinones and quinazolinones
12. 8440693 - Substituted isoquinolinones and quinazolinones
13. 8163773 - Organic compounds